KURA logo

Kura Oncology (KURA) Cash And Cash Equivalents

Annual Cash & Cash Equivalents

$224.46 M
+$187.14 M+501.48%

December 31, 2024


Summary


Performance

KURA Cash And Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherKURAbalance sheetmetrics:

Quarterly Cash And Cash Equivalents

$224.46 M
+$174.98 M+353.64%

December 31, 2024


Summary


Performance

KURA Quarterly Cash And Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherKURAbalance sheetmetrics:

Cash And Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

KURA Cash And Cash Equivalents Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+501.5%+501.5%
3 y3 years+147.6%+501.5%
5 y5 years+758.9%+501.5%

KURA Cash And Cash Equivalents Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+501.5%at high+729.5%
5 y5-year-31.0%+758.9%-31.0%+758.9%
alltimeall time-31.0%>+9999.0%-31.0%+3209.2%

Kura Oncology Cash And Cash Equivalents History

DateAnnualQuarterly
Dec 2024
$224.46 M(+501.5%)
$224.46 M(+353.6%)
Sep 2024
-
$49.48 M(+9.5%)
Jun 2024
-
$45.18 M(+8.9%)
Mar 2024
-
$41.51 M(+11.2%)
Dec 2023
$37.32 M(-28.0%)
$37.32 M(+29.8%)
Sep 2023
-
$28.74 M(-41.5%)
Jun 2023
-
$49.12 M(+81.5%)
Mar 2023
-
$27.06 M(-47.8%)
Dec 2022
$51.80 M(-42.9%)
$51.80 M(-43.0%)
Sep 2022
-
$90.94 M(+131.6%)
Jun 2022
-
$39.26 M(+16.0%)
Mar 2022
-
$33.83 M(-62.7%)
Dec 2021
$90.67 M(-72.1%)
$90.67 M(+131.4%)
Sep 2021
-
$39.18 M(+0.5%)
Jun 2021
-
$38.97 M(-64.8%)
Mar 2021
-
$110.83 M(-65.9%)
Dec 2020
$325.49 M
$325.49 M(+323.0%)
Sep 2020
-
$76.95 M(-42.9%)
Jun 2020
-
$134.76 M(+298.6%)
DateAnnualQuarterly
Mar 2020
-
$33.81 M(+29.4%)
Dec 2019
$26.14 M(+62.1%)
$26.14 M(-52.3%)
Sep 2019
-
$54.74 M(-55.2%)
Jun 2019
-
$122.08 M(+586.7%)
Mar 2019
-
$17.78 M(+10.3%)
Dec 2018
$16.12 M(+41.0%)
$16.12 M(-21.6%)
Sep 2018
-
$20.57 M(+16.5%)
Jun 2018
-
$17.66 M(-33.4%)
Mar 2018
-
$26.52 M(+131.9%)
Dec 2017
$11.43 M(+17.6%)
$11.43 M(-51.0%)
Sep 2017
-
$23.34 M(+92.0%)
Jun 2017
-
$12.15 M(+14.2%)
Mar 2017
-
$10.64 M(+9.4%)
Dec 2016
$9.72 M(-37.0%)
$9.72 M(+43.4%)
Sep 2016
-
$6.78 M(-44.0%)
Jun 2016
-
$12.11 M(-25.8%)
Mar 2016
-
$16.33 M(+5.7%)
Dec 2015
$15.44 M(+1273.9%)
$15.44 M(+37.7%)
Sep 2015
-
$11.21 M
Dec 2014
$1.12 M
-

FAQ

  • What is Kura Oncology annual cash & cash equivalents?
  • What is the all time high annual cash & cash equivalents for Kura Oncology?
  • What is Kura Oncology annual cash & cash equivalents year-on-year change?
  • What is Kura Oncology quarterly cash and cash equivalents?
  • What is the all time high quarterly cash and cash equivalents for Kura Oncology?
  • What is Kura Oncology quarterly cash and cash equivalents year-on-year change?

What is Kura Oncology annual cash & cash equivalents?

The current annual cash & cash equivalents of KURA is $224.46 M

What is the all time high annual cash & cash equivalents for Kura Oncology?

Kura Oncology all-time high annual cash & cash equivalents is $325.49 M

What is Kura Oncology annual cash & cash equivalents year-on-year change?

Over the past year, KURA annual cash & cash equivalents has changed by +$187.14 M (+501.48%)

What is Kura Oncology quarterly cash and cash equivalents?

The current quarterly cash and cash equivalents of KURA is $224.46 M

What is the all time high quarterly cash and cash equivalents for Kura Oncology?

Kura Oncology all-time high quarterly cash and cash equivalents is $325.49 M

What is Kura Oncology quarterly cash and cash equivalents year-on-year change?

Over the past year, KURA quarterly cash and cash equivalents has changed by +$187.14 M (+501.48%)